Silver Book

Silver Book Fact

“Sherri Selph was 41 when she was first diagnosed with second-stage congestive heart failure. However, her rapidly diminishing health led to a diagnosis of end-stage heart disease. A heart transplant was not an option. Survival statistics for patients with Sherrie’s condition are grim. Even with the best treatment available, only 50 percent of heart failure patients live beyond a year.
Her doctor suggested that Sherri enroll in a clinical trial. Sherri soon became a patient and a member of the group that received an implantable heart pump.
The results were immediate. Four days after receiving her heart pump Sherri was back on her feet. ‘I could not believe it. The pump had given me back my life,’ she said. ‘Without this procedure, I would not have lived to see my youngest grandson who is now two and a half years old.’ Sherri is now back in South Carolina with her heart pump and her five grand-children, who prefer that she stay right where she is.”

Investment in Research Saves Lives and Money. http://www.researchamerica.org/advocacy/investment.html. Published 2005

Reference

Title
Investment in Research Saves Lives and Money
Publisher
Research!America
Publication Date
Published 2005
Authors
Research!America
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Increased use of a blood-thinning drug saves $600 million annually, because of the strokes it prevents.  
  • A recent data analysis of more than 2,700 stroke patients from the U.S. and Europe confirmed tPA’s effectiveness, which could save the U.S. nearly $50 million a year.  
  • Effect of optimal anticoagulation
    If 50% of atrial fibrillation patients who currently receive warfarin in routine medical care were optimally anticoagulated, 9,852 emboli would be prevented and $1.3 billion would be saved each year.  
  • Pioglitazone associated with relative risk reduction in recurrent stroke
    The PROactive trial to manage glucose in diabetics with a history of cardiovascular disease, stroke, or other vascular risk factors found that treatment with pioglitazone was associated with a 47% relative…  
  • Because of the advent of imaging and noninvasive testing, Americans who are asymptomatic are being diagnosed with established cardiovascular disease.